Management of severe hypertension.
D001581:Benzothiadiazines / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004039:Diet, Sodium-Restricted; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D008750:Methyldopa / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D012964:Sodium / Q000009:adverse effects / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use
D001581:Benzothiadiazines; D004983:Ethanolamines; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D008914:Minoxidil; D012964:Sodium; D011433:Propranolol; D012083:Renin; D003000:Clonidine; D003981:Diazoxide